Metabolomic Profiling of Wildtype and Transgenic Giardia lamblia Strains by ¹H HR-MAS NMR Spectroscopy

SPECIAL REPORT

HIV / AIDS

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

SPECIAL REPORT

HIV / AIDS

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021

SPECIAL REPORT

Viral Infections, Non-HIV

Prévention efficace et bien tolérée avec le nouvel inhibiteur de la terminase Prevymis^®1,2

SPECIAL REPORT

Viral Infections, Non-HIV

Wirksame und verträgliche Prophylaxe mit dem neuen Terminaseinhibitor Prevymis^®1,2

COMMENTED

Neuropathic Pain

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

★ 2 Recommended and commented by Prof. Dr emer. Josef Flammer, Faculty Member

BMJ

Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, Tunnicliffe D, Ruospo M, Natale P, Saglimbene V, Nicolucci A, Johnson DW, Tonelli M, Rossi MC, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque LI, Lloyd A, Ahmad N, Liu Y, Tiv S, Millard T, Gagliardi L, Kolanu N, Barmanray RD, McMorrow R, Raygoza Cortez AK, White H, Chen X, Zhou X, Liu J, Rodríguez AF, González-Colmenero AD, Wang Y, Li L, Sutanto S, Solis RC, Díaz González-Colmenero F, Rodriguez-Gutierrez R, Walsh M, Guyatt G, Strippoli GFM

doi: 10.1136/bmj.m4573

SPECIAL REPORT

Bacterial InfectionsViral Infections, Non-HIV

Infections récidivantes chez les patients greffés immunodéprimés

HIV / AIDS

Impact of HIV infection on the course of inflammatory bowel disease and drug safety profile: a multicenter GETAID study

Clin Gastroenterol Hepatol

Guillo L, Uzzan M, Beaugerie L, Gornet JM, Amiot A, Pelletier AL, Altwegg R, Laharie D, Abitbol V, Filippi J, Goutorbe F, Nachury M, Nancey S, Viennot S, Reenaers C, Amil M, Caillo L, Buisson A, Collins M, Picon L, Vidon M, Benezech A, Rabaud C, Baumann C, Rousseau H, Dubourg G, Serrero M, Peyrin-Biroulet L

doi: 10.1016/j.cgh.2020.12.023

Drug ResistanceParasitic Infection

Resistance formation to nitro drugs in Giardia lamblia: No common markers identified by comparative proteomics

Int J Parasitol Drugs Drug Resist.

Müller J, Braga S, Heller M, Müller N

doi: 10.1016/j.ijpddr.2019.03.002.

Viral Infections, Non-HIV

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial

Lancet Infect Dis.

Forns X, Lee SS, Valdes J, Lens S, Ghalib R, Aguilar H, Felizarta F, Hassanein T, Hinrichsen H, Rincon D, Morillas R, Zeuzem S, Horsmans Y, Nelson DR, Yu Y, Krishnan P, Lin CW, Kort JJ, Mensa FJ

doi: 10.1016/

Related content

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

11e Conférence de la Société internationale sur le SIDA (IAS) 2021

Prévention efficace et bien tolérée avec le nouvel inhibiteur de la terminase Prevymis®1,2

Wirksame und verträgliche Prophylaxe mit dem neuen Terminaseinhibitor Prevymis®1,2

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

Infections récidivantes chez les patients greffés immunodéprimés

Impact of HIV infection on the course of inflammatory bowel disease and drug safety profile: a multicenter GETAID study

Resistance formation to nitro drugs in Giardia lamblia: No common markers identified by comparative proteomics

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021

Prévention efficace et bien tolérée avec le nouvel inhibiteur de la terminase Prevymis^®1,2

Wirksame und verträgliche Prophylaxe mit dem neuen Terminaseinhibitor Prevymis^®1,2